Goldman Sachs Starts Codiak Biosciences Inc. (CDAK) at Buy

November 8, 2020 9:44 PM EST
Get Alerts CDAK Hot Sheet
Price: $17.20 -8.75%

Rating Summary:
    3 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 17 | Down: 5 | New: 36
Trade Now! 
Join SI Premium – FREE

Goldman Sachs initiates coverage on Codiak Biosciences Inc. (NASDAQ: CDAK) with a Buy rating and a price target of $29.00.


For an analyst ratings summary and ratings history on Codiak Biosciences Inc. click here. For more ratings news on Codiak Biosciences Inc. click here.


Shares of Codiak Biosciences Inc. closed at $9.06 yesterday.


You May Also Be Interested In





Related Categories

New Coverage